دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
Vijairam Selvaraj MD, MPH, Saurav Chatterjee MD, Taishi Hirai MD, J. Dawn Abbott MD, Chirag Bavishi MD, MPH
doi : 10.1002/ccd.30467
The American Heart Association/American College of Cardiology guidelines on dual antiplatelet therapy (DAPT) recommend at least 12 months of a P2Y12 inhibitor and low dose aspirin in patients with an acute coronary syndrome (ACS) treated with a stent.
Evaluation of factors associated with selection for coronary angiography and in-hospital mortality among patients presenting with out-of-hospital cardiac arrest without ST-segment elevation
Wayne C. Zheng MD, Samer Noaman MBChB, Riley J. Batchelor MBBS, Laura Hanson MD, Jason E. Bloom MBBS, Omar Al-Mukhtar MBBS, Kawa Haji MBBS, Nicholas D'Elia MBBS, Felicia C. S. Ho MD, David Kaye MBBS, PhD, James Shaw MBBS, PhD, Yang Yang MBBS, Craig French MBBS, Dion Stub MBBS, PhD, Nicholas Cox MBBS, William Chan MBBS, PhD
doi : 10.1002/ccd.30442
Clinical factors favouring coronary angiography (CA) selection and variables associated with in-hospital mortality among patients presenting with out-of-hospital cardiac arrest (OHCA) without ST-segment elevation (STE) remain unclear.
Coronary angiography after resuscitation without ST-Elevation: Indication remains elusive
Francois P. Kaleta DO, Ian C. Gilchrist MD, MSCAI
doi : 10.1002/ccd.30499
Acute myocardial infarction caused by Kawasaki disease requires more intensive therapy: Insights from the Japanese registry of All Cardiac and Vascular Diseases�Diagnosis Procedure combination
Fumiya Anzai MD, PhD, Akiomi Yoshihisa MD, PhD, Ryohei Takeishi MD, Yu Hotsuki MD, PhD, Yu Sato MD, PhD, Yoko Sumita, Michikazu Nakai, Tomofumi Misaka MD, PhD, Yasuchika Takeishi MD, PhD
doi : 10.1002/ccd.30457
Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients
Sanjana Nagraj MBBS, Andreas Tzoumas MD, Fotis Kakargias MD, Stefanos Giannopoulos MD, Athina Ntoumaziou MD, Damianos G. Kokkinidis MD, MSc, Miguel Alvarez Villela MD, Azeem Latib MD
doi : 10.1002/ccd.30446
To compare the outcomes of hybrid coronary revascularization (HCR) with traditional coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD).
Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis
Daniel Faria MD, Hernan Mejia-Renteria MD, PhD, Joo Myung Lee MD, MPH, PhD, Seung Hun Lee MD, Alejandro Travieso MD, Ji-Hyun Jung MD, Joon-Hyung Doh MD, PhD, Chang-Wook Nam MD, PhD, Eun-Seok Shin MD, PhD, Masahiro Hoshino MD, Tomoyo Sugiyama MD, Yoshihisa Kanaji MD, Nieves Gonzalo MD, PhD, Tsunekazu Kakuta MD, PhD, Bon-Kwon Koo MD, PhD, Javier Escaned MD, PhD
doi : 10.1002/ccd.30445
Investigate age-related changes in coronary microvascular function, its effect on hyperemic and non-hyperemic indices of stenosis relevance, and its prognostic implications.
Age and the cascade impact on coronary flow reserve (CFR) and discordance of fractional flow reserve and non-hyperemic pressure ratios (NHPR)
Morton J. Kern MD, MSCAI, FAHA
doi : 10.1002/ccd.30502
Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio
Hyun-Jong Lee MD, PhD, Hernán MejÃa-RenterÃa MD, PhD, Javier Escaned MD, PhD, Joon-Hyung Doh MD, PhD, Joo Myung Lee MD, PhD, Doyeon Hwang MD, Sonoka Yuasa MD, Ki Hong Choi MD, Ho-Jun Jang MD, Ki-Hyun Jeon MD, Juneyoung Lee PhD, Chang-Wook Nam MD, PhD, Eun-Seok Shin MD, PhD, Bon-Kwon Koo MD, PhD
doi : 10.1002/ccd.30451
The clinical value of residual quantitative flow ratio (rQFR), a novel function of QFR technique, is unknown.
The future of angiography: Estimates of FFR pre- and post-PCI
David M. Tehrani MD, MS, Arnold H. Seto MD, MPA
doi : 10.1002/ccd.30492
Intravascular imaging for left main stem assessment: An update on the most recent clinical data
Bernardo Cortese MD, FESC, Davide Piraino MD, Domitilla Gentile MD, Horea-Laurentiu Onea MD, Leontin Lazar MD
doi : 10.1002/ccd.30440
Left main (LM) stem has different structural and anatomical characteristics compared to all of the other segments of the coronary tree, thus its management through percutaneous coronary intervention (PCI) is a challenge and is associated with worse clinical outcome and higher need for revascularization as compared to other lesion settings.
Revascularization and long-term outcomes in high-acuity spontaneous coronary artery dissection
Christina Thaler MD, Dawn R. Witt PhD, MPH, Timothy D. Henry MD, Elizabeth Z. Grey MD, Courtney J. Baechler MD, Opema Lohese BS, Brynn K. Okeson MS, Christian W. Schmidt MS, Scott W. Sharkey MD
doi : 10.1002/ccd.30448
Spontaneous coronary artery dissection (SCAD) is often treated conservatively due to revascularization risks. Yet, an important number of SCAD patients have high acuity characteristics necessitating revascularization, with uncertain long-term outcomes.
Underweight and obesity are related to higher mortality in patients undergoing coronary angiography: The KARDIO invasive cardiology register study
Jari A. Laukkanen MD, PhD, Setor K. Kunutsor MD, PhD, Jussi Hernesniemi MD, PhD, Jaakko Immonen MSc, Markku Eskola MD, PhD, Francesco Zaccardi MD, PhD, Matti Niemelä MD, PhD, Timo Mäkikallio MD, PhD, Magnus Hagnäs MD, PhD, Jarkko Piuhola MD, PhD, Jukka Juvonen MD, PhD, Jussi Sia MD, Juha Rummukainen MD, Kari Kervinen MD, PhD, Juha Karvanen DSc (Tech.), Kjell Nikus MD, PhD, KARDIO Study Group
doi : 10.1002/ccd.30463
In patients with some cardiovascular disease conditions, slightly elevated body mass index (BMI) is associated with a lower mortality risk (termed “obesity paradox�).
Coronary angiography of the ex-situ beating donor heart in a portable organ care system
Thomas Meredith BMed, MD, MClinTRes, FRACP, Sarah Scheuer MBBS, PhD, Michael Hoffman BMI, Yashutosh Joshi MBBS, Krishna Kathir MBBS, PhD, FRACP, Brendan Gunalingam MBBS, FRACP, David Roy MBChB, FRACP, Stephanie Wilson MBBS, PhD, FRACP, Paul Jansz MBBS, PhD, FRACS, Peter Macdonald MBBS, PhD, FRACP, David Muller MBBS, MD, FRACP
doi : 10.1002/ccd.30455
To cater for the perpetually growing demand for heart donors, interest in donation following circulatory death (DCD) has been rekindled.
A new FDA approved stent for congenital heart disease:Â First-in-man experiences with G-ARMORTM
Gareth J. Morgan MD, Jenny Zablah MD
doi : 10.1002/ccd.30447
We present the first clinical experience with a new hybrid cell structure covered stent, designed for congenital heart disease applications. It represents a significant redesign of the Cheatham Platinum (CP) Stent (Numed Inc.), maintaining the traditional benefits of the covered CP whilst significantly decreasing shortening and allowing controlled flaring at the ends through its combination of larger and standard sized cells.
Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms
Iman Naimi MD, Brian Morray MD, Michael A. Portman MD, Zachary L. Steinberg MD
doi : 10.1002/ccd.30458
Kawasaki disease (KD) is an acute vasculitis that can cause coronary artery inflammation and aneurysm formation leading to early obstructive disease.
Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
Young-Guk Ko MD, Donghoon Choi MD, PhD, Seung-Woon Rha MD, PhD, Je Hwan Won MD, Young-Soo Do MD, Seung-Whan Lee MD, Jeremiah S. Menk MS, Steven Kum MD
doi : 10.1002/ccd.30441
The long-term data on the use of drug-coated balloons (DCBs) for femoropopliteal atherosclerotic lesions in the real-world setting are limited, even more so for racially and geographically distinct populations. The present analysis reports the 5-year safety and effectiveness outcomes of a DCB in the Asian subset of the prospective, real-world IN.PACTÂ Global Study.
Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years
John G. Winscott MD, William B. Hillegass MD, PhD
doi : 10.1002/ccd.30500
Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis
Daniel Tébar Márquez MD, Raul Moreno MD, PhD, Guillermo Galeote MD, PhD, Alfonso Jurado-Roman MD, PhD, Santiago Jimenez-Valero MD, PhD, Artemio GarcÃÂa-Escobar MD, Silvio Vera MD, Isidro Moreno-Gómez MD, PhD, Esteban Lopez de Sa MD, PhD
doi : 10.1002/ccd.30449
The aim of this study was to describe the procedural and early outcomes of patients with mechanical mitral valve prosthesis (MVP) undergoing transcatheter aortic valve replacement (TAVR) with a novel self-expandable retrievable device.
Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results
Stephan Baldus MD, Niklas Schofer MD, Jörg Hausleiter MD, Kai Friedrichs MD, P. Lurz MD, Philipp Luedike MD, Christian Frerker MD, G. Nickenig MD, Edith Lubos MD, Roman Pfister MD, M. I. Körber MD, Daniel Kalbacher MD, Michael Näbauer MD, C. Besler MD, Amir Abbas Mahabadi MD, Marcel Weber MD, M. Zdanyte MD, C. B. Ren MD, PhD, Tobias Geisler MD
doi : 10.1002/ccd.30450
Severe tricuspid regurgitation (TR) is independently associated with increased morbidity and mortality. Percutaneous transcatheter approaches may offer an alternative for patients not amenable to surgery.
Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
Milad El Hajj MD, Zvonimir Krajcer MD
doi : 10.1002/ccd.30497
Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience
Michael Michail, James Cockburn, Kristoffer Vincent P. Tanseco, Sandeep Arunothayaraj, Andrew Hill, Uday Trivedi, David Hildick-Smith
doi : 10.1002/ccd.30465
We report a single-center experience in utilizing the transcaval-access transcatheter aortic valve implantation (TAVI) as an alternative approach in morbidly obese patients.
Predictors of successful same-day discharge and 1-year outcomes after left atrial appendage closure
Sojin Youn Wass MD, Jason Galo MD, Sung-Han Yoon MD, Luis A. P. Dallan MD, PhD, Akhil Mogalapalli MD, Anene Ukaigwe MD, Guilherme F. Attizani MD, Daniel I. Simon MD, Mauricio Arruda MD, Steven J. Filby MD
doi : 10.1002/ccd.30464
Same-day discharge (SDD) following left atrial appendage closure (LAAC) is increasingly common but predictors of successful SDD and 1-year clinical outcomes have not been described.
Same-day discharge after left atrial appendage occlusion: Is ICE-guided LAAO ready for prime time?
Sahil Khera MD, MPH, George Dangas MD, PhD, MSCAI
doi : 10.1002/ccd.30509
Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography
Richard Tanner MB, BCh, BAO MRCPI, Sean Murphy MB, BCh, BAO MRCPI, Ciara Malone MB, BCh, BAO, BSc, MRCPI, Catherine McGorrian MRCPI, MSc, PhD, Declan Sugrue MD, FRCPI, FACC, FESC, David Barton MB, BCh, FACC, Roger Byrne BA, MB, BCh, MRCPI, Gavin Blake MD, MPH, MSc, FRCPI, Ronan Margey MB, MSc, MRCPI, FESC, FSCAI, FACC, Ivan P. Casserly MB, BCh, MRCPI, FSCAI, FACC
doi : 10.1002/ccd.30469
To assess the correlation between the aortic valve annular plane (AVAP) obtained by preprocedural computed tomography (CT) with on-table three-dimensional rotational angiography (3DRA), in patients undergoing transcatheter aortic valve replacement (TAVR).
Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention
Muhammed Gerçek MD, Anca A. Irimie MD, Mustafa Gerçek MD, Henrik Fox MD, Vera Fortmeier MD, Tanja K. Rudolph MD, Volker Rudolph MD, Kai P. Friedrichs MD
doi : 10.1002/ccd.30443
This study evaluates the impact of transcatheter tricuspid valve interventions (TTVI) on cognitive function (CF), quality of life (QOL), and exercise capacity in late-stage heart failure with preserved ejection fraction (HFpEF) and relevant tricuspid regurgitation (TR).
Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding
Masaki Yashige MD, Kan Zen MD, PhD, Kazuaki Takamatsu MD, Satoaki Matoba MD, PhD
doi : 10.1002/ccd.30444
Transcatheter aortic valve replacement (TAVR) is a well-established treatment for severe aortic stenosis.
